OBJECTIVES: Scanty data are available on 'second cross-clamping' following mitral valve repair in contemporary practice. The aim of this study was to evaluate the incidence, causes and outcomes of this event in patients referred for mitral repair for severe degenerative mitral regurgitation (MR).
INTRODUCTION
Mitral valve (MV) reconstruction is the gold standard for the treatment of degenerative MV disease [1, 2] . To achieve long-term durability of the repair, it is very important to have, at transoesophageal echocardiography (TOE), after weaning from cardiopulmonary bypass (CPB), no (or only trivial) residual mitral regurgitation (MR), a good length of leaflet coaptation, a sufficient valve area and no iatrogenic stenosis. The absence of any significant leak after repair is particularly important because residual, greater-than-trivial MR is a risk factor for late reoperation [3] [4] [5] [6] .
The mechanism of residual MR can be related to left ventricular (LV) dysfunction, systolic anterior motion (SAM) or anatomical factors (such as residual prolapse, clefts, suture dehiscence or partial ring detachment) [3, [7] [8] [9] . Functional mechanisms can often be corrected by medical management [10] . On the other hand, the anatomical ones (including refractory SAM) usually need a surgical revision of the MV during the same operation. Because suboptimal immediate results are associated with †Presented at the 31st Annual Meeting of the European Association for CardioThoracic Surgery, Vienna, Austria, 7-10 October 2017. ‡The first two authors contributed equally to this work and should be regarded as co-first authors.
impaired late outcomes of MV reconstruction [4, 5] , a low threshold for a second cross-clamping seems to be justified. However, longer CPB and aortic cross-clamping times carry an increased risk of postoperative morbidity, which should be considered when assessing the need for a second repair attempt. Only scanty data are available on incidence, causes and outcomes of 'second cross-clamping' following MV repair in contemporary practice and, for this reason, we decided to assess these issues in a series of patients referred for MV repair for severe degenerative MR in our institution.
METHODS

Patients
Our hospital database was retrospectively used to identify patients requiring a second cross-clamping after MV repair. The study population included 2318 patients with severe degenerative MR referred for mitral repair from 2003 to 2015. Patients with non-degenerative or mixture of functional and degenerative aetiology of MR and those undergoing concomitant aortic valve replacement and/or myocardial revascularization were excluded. Of the 2318 patients, 94 (4%) patients underwent a second crossclamping ('second cross-clamping' group). Causes of the second cross-clamping, revising repair procedures, immediate final echocardiographic outcomes and postoperative course were assessed. The 2224 patients belonging to the 'single cross-clamping' group were used as the control for hospital outcomes. Late clinical and echocardiographic follow-up was obtained for the 'second cross-clamping' patients. The institutional ethics committee approved the study and waived the informed consent for this retrospective analysis.
The most relevant preoperative and intraoperative data of the 'second cross-clamping' and control groups are reported in Table 1 . Most of the patients in both groups had myxomatous MV disease and posterior leaflet prolapse and were in New York Heart Association (NYHA) Class I or II. The spectrum of degenerative diseases ranges from myxomatous disease to fibroelastic deficiency. The definitive diagnosis was made intraoperatively. Patients were classified as having myxomatous disease when the valve had redundant white and voluminous tissue, annular dilation and chordae elongation; they were instead classified as having fibroelastic deficiency when the valve was found to be thin, frail, translucent and with broken chordae. Mean ejection fraction was 60.9 ± 7.2% in the control group and 61.4 ± 7.1% in the second cross-clamping group (P = 0.56). Mean LV volume was 128.62 ± 43.32 ml, mean LV enddiastolic diameter was 57.89 ± 7.13 mm and systolic pulmonary arterial pressure (SPAP) was 37.71 ± 11.3 mmHg. There were no differences in the variables listed between the 2 groups. Only age was significantly lower in the control patients. Aortic cross-clamping time of the first procedure was significantly longer in the 'second cross-clamping', indicating a more complex and time-consuming valve analysis to apply the best fitting repair technique.
Echocardiographic study
All patients underwent preoperative TOE. The degree of MR was measured semi-quantitatively by Doppler colour flow imaging and defined as mild (1+/4+) if the percentage of the left atrial area subtended by the MR jet was 1-15%, moderate (2+/4+) if it 
Surgical technique of the initial mitral repair
In the overall population of 2318 patients, surgical access was either through a midline sternotomy or a right minithoracotomy incision. The MV was exposed through the left atrium with the incision done in the interatrial groove. Quadrangular/triangular resection (±sliding/folding plasty) was the surgical technique used in more than half of the patients. Posterior leaflet resection with annular plication was rarely performed during this period. The edge-to-edge (EE) repair was used in about 28% of cases and almost exclusively in bileaflet and anterior leaflet prolapse. Artificial chordae were preferred in a minority of patients because, in the study time frame, they were used less commonly in our institution.
In about 30% of patients, a combination of different techniques including resection, neochordae, cleft closure and EE were necessary to treat multiple MV lesions (Table 1) . A ring annuloplasty was performed in 98.8% of the patients. A complete rigid or semi-rigid ring was used in 454 of 2318 (19.5%) patients and a flexible band in the remaining 80.5%. The mean size was 33.73 ± 5.64 mm and 33.49 ± 2.7 mm in the second cross-clamping group and in the control group, respectively. The most common associated procedures included tricuspid annuloplasty (437 patients, 18.8%) and radiofrequency ablation of atrial fibrillation (199 patients, 8.5%). After weaning from CPB, a TOE control was performed. If SAM was detected, a conservative management, consisting of intravascular volume expansion, discontinuation of inotropic drugs and administration of beta-blockers, was first attempted [9] . A second cross-clamping for surgical revision of the MV was started if SAM with LV outflow tract obstruction gradient and/or significant MR persisted, despite conservative manoeuvres or whenever at least residual moderate MR not related to SAM was detected.
Follow-up
Follow-up data were obtained for the 'second cross-clamping' group by means of outpatient visits including a transthoracic echocardiography examination performed in our institution or by means of telephone interview with the patients and the referring cardiologists. Clinical and echocardiographic follow-up information was available for 91 patients (97% complete) with a mean time of 6.7 ± 4 years [median 6 years, interquartile range (IQR) [3] [4] [5] [6] [7] [8] [9] [10] [11] . Three patients were lost to follow-up. The first Doppler echocardiographic study demonstrating moderate-to-severe MR or severe MR was considered 'MR recurrence'. Clinical and echocardiographic follow-up performed within the last 6 months from data collection were defined as 'complete follow-up'. For patients who died or underwent reoperation, clinical and Doppler echocardiographic data refer red to the recent findings that were available before the event.
Statistical analysis
Data were expressed as mean ± standard deviation or as median and IQR. The Shapiro-Wilk test was used to assess whether the distribution was normal or non-normal. The qualitative variables were compared by the v 2 test or the Fisher's exact test (when frequency in one cell was <5) when appropriate. Comparison of continuous data (expressed as mean ± standard deviation) was performed with the Student's t-test for (un)paired samples as indicated. The Mann-Whitney U-test was used for independent samples [expressed as median (IQR)] when continuous data were not normally distributed. The degree of MR was treated as an ordinal variable and compared with the Wilcoxon signed-rank test (related samples) or with the Mann-Whitney U-test (independent samples). Logistic regression analysis was performed to evaluate potential predictors of second cross-clamping (odds ratios) and 95% confidence intervals (CIs). Logistic regression analysis was performed to evaluate potential predictors of second crossclamping. Survival was analysed with the Kaplan-Meier estimator. Cumulative incidence function (CIF) was computed for reoperation and for recurrence of MR > _ 3+ and for MR > _ 2+, with death as a competing risk.
Statistical analyses were performed with Stata software version 13 and R software.
RESULTS
Incidence of second cross-clamping
Of the 2318 patients, 94 (4.2%) patients underwent a second cross-clamping because of an unsatisfactory result of the initial MV repair at the intraoperative TOE control. This rate remained stable from 2003 to 2015, ranging from 3.3% to 5.2% without a statistically significant difference between the 3 considered consecutive time frames (2003-2006, 2007-2010 and 2011-2015) (P = 0.25).
Logistic regression analysis was performed to evaluate potential risk factors for a second cross-clamping in the overall study population of 2318 patients. Older age, bileaflet prolapse and, not surprisingly, longer cross-clamp time were identified as significant risk factors for this event. Interestingly, among the surgical techniques most commonly used (resection, EE and artificial chordae), the adoption of the EE repair was found to significantly decrease the risk of a second cross-clamping after the procedure (odds ratio 0.34, P = 0.028, 95% CI 0.130-0.889) ( Table 2) .
Causes of second cross-clamping and rescue procedures
In the 'second cross-clamping' group, the initial repair attempt performed was a resection of the posterior leaflet (with/without folding/sliding plasty) in 53 (56.4%) patients, an EE repair in 18 (19.2%) patients, artificial chordae implantation in 8 (8.5%) patients and a combination of at least 2 techniques in 15 (16%) patients. Of the 94 patients, only 1 (1.05%) patient did not receive an associated annuloplasty. The most frequent causes of the second cross-clamping were residual moderate MR (vena contract >0.3) and SAM. The causes and the relative rescue procedures are detailed in Table 3 . A residual prolapse was the most common cause for MR and was identified in 41 of 94 (43.5%) patients. In the majority of cases, an EE suture was used to rescue these valves without taking down the primary repair (35 of 41, 85.3%). Artificial chordae implantation (4 of 41, 9.7%), quadrangular resection (1 of 41, 2.4%) and cleft closure (1 of 41, 2.4%) were used in the remaining 15% of patients.
SAM with significant MR (with or without LV outflow tract) made necessary a second cross-clamping in 22 of 94 (23.4%) patients who were refractory to conservative treatments [9] . When refractory SAM was treated with a rescue EE repair [12] , the procedure was exclusively echo guided. Indeed, the EE suture was placed centrally or in correspondence with one commissure depending on which part of the MV was responsible for LV outflow tract obstruction on TOE. Implantation of larger annuloplasty rings or short neochordae on the posterior leaflet were other rescue procedures used in this setting.
In 14 of 94 (15%) patients, residual MR was attributed by TOE to untreated clefts in the posterior leaflet. Cleft closure alone was performed in 10 (71%) patients. In the remaining 4 patients, however, the mechanism was not correctly identified and cleft closure was not sufficient to restore valve competence, which was achieved only after adding an EE suture.
Other less common mechanisms of a suboptimal MV repair were tissue laceration, ring dehiscence, mitral stenosis, leaflet restriction, residual annular dilatation or a combination of them.
Mean second CPB and aortic cross-clamping times were 36 (range 28-50) and 23 (range 17-34) min, respectively.
Hospital outcome
There were no hospital deaths in the second cross-clamping group, whereas 7 patients died in the control group (7 of 2224, 0.3%) (P = 0.2). Postoperatively, there was a trend towards a higher rate of intra-aortic balloon pump (IABP) need in the second cross-clamping group (5.3% vs 2.5%, P = 0.09), although this difference did not reach statistical significance. Despite longer overall cross-clamping and CPB times, postoperative complications of the patients requiring a revision of the mitral repair did not show a statistical difference when compared with those registered in the 'single cross-clamping' cases ( Table 4 ). The length of hospital stay did not show a statistical difference between the 2 groups (7.0 ± 9.0 vs 7.2 ± 5.3) with a median of 5 days (IQR 4-7) (P = 0.61). The TOE performed after the second cross-clamping 2 ) were considered acceptable only in 2 patients with a body surface area < _1.6 m 2 [13] . At discharge, the rate of suboptimal result (residual moderate MR) was 2 of 94 (2.1%) patients in the second cross-clamping and 61 of 2224 (2.7%) patients in the control group (P = 0.99). One patient had residual moderate MR after quadrangular leaflet resection as the first operation and a cleft closure as a rescue technique, and the result was considered acceptable because of the evidence of ischaemia at the electrocardiogram monitor. The other patient (1 of 94, 1%) required MV replacement after a resection technique in the postoperative period, following a failed attempt to treat refractory SAM (causing a moderate MR) with an EE repair.
Late results
Late clinical and echocardiographic follow-up was performed only for the 'second cross-clamping' group and was obtained in 91 (97% complete) patients at a median time of 6 years (IQR 3-11, mean 6.7 ± 4 years). Three patients died after hospital discharge: 1 patient had a sudden death 2 months after the operation and 2 patients died 6 months after surgery (1 malignant arrhythmia and 1 unknown). Because all deaths were considered cardiac related, the overall survival corresponds to the freedom from cardiac death and was 96 ± 2% at 12 years. Five patients had to be reoperated for recurrent severe MR between 6 months and 13 years after the initial repair (2 patients after 6 months, 1 patient after 10 months, 1 patient after 3 years and 1 patient after 13 years). At 12 years, the CIF of reoperation on the MV with death as competing risk was 5.7 ± 2.5% (95% CI 2-12) (Fig. 1) .
The last follow-up transthoracic echocardiography demonstrated that MR was absent or mild in 78 (86%) patients, moderate in 5 (5.5%) patients, and severe in 7 (7.7%) patients. At 12 years, the CIF of recurrent moderate-to-severe MR with death as competing risk was 10.3 ± 4.3% (95% CI 3.8-20) (Fig. 2) . When moderate MR was considered, the CIF of this event with death as competing risk was 17 ± 5.2% (95% CI 8-29) at 12 years (Fig. 3) .
At follow-up, 82 (90%) patients were in sinus rhythm, 7 (7.7%) in persistent/permanent atrial fibrillation and 1 had a pacemaker-induced rhythm. A significant clinical improvement was also documented because all patients were in NYHA functional class I (94.4%) or II (5.6%) at follow-up, whereas before surgery, 16 (17.4%) patients were in NYHA functional class III or IV (P < 0.01).
DISCUSSION
This study demonstrates that, in a large volume centre for mitral repair, a second cross-clamping is still performed in about 4% of 
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Low cardiac output syndrome, n (%) the patients. Residual prolapse, SAM and untreated clefts represent the most common causes for revising the repair. If the additional cross-clamping time is relatively short, mortality and morbidity are not increased compared with single CPB cases. Both residual MR and SAM can be effectively corrected in almost all patients and excellent long-term results can be achieved. The issue of achieving a perfect result after MV repair is very important because, according to current guidelines, even asymptomatic patients without LV dilatation/dysfunction, in sinus rhythm and without pulmonary hypertension can be considered for an early repair if the likelihood of a successful and durable reconstruction is very high [1, 2] . It is well known that an initial suboptimal result after repair is a risk factor for late reoperation [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . In the presence of significant residual MR and/or refractory SAM, the repair needs to be surgically revised. Old studies report an incidence of 7-10% in patients with different aetiologies of MR [3, 8, 9, 12, 14, 16] .
In our institution, the rate of second cross-clamping following MV repair for degenerative MR was 11% in the year 2000-2001 [9] . Results have progressively improved, and we decided to assess this important issue in a series of 2318 patients with pure degenerative MR undergoing MV repair more recently. To the best of our knowledge, this is the largest series reported so far dealing with patients undergoing a second cross-clamping after an initial repair for pure degenerative MR. Older age and bileaflet prolapse were identified as significant preoperative risk factors for second cross-clamping. Among the intraoperative variables, a longer cross-clamp time was a predictor probably because it is a marker of a more challenging repair procedure. Finally, the adoption of the EE repair was found to significantly decrease the risk of a second cross-clamping.
In the majority of cases, the first operation performed in patients undergoing a 'second cross-clamping' was posterior leaflet resection, followed by EE technique and artificial chordae. The most common cause of second cross-clamping was moderate MR (75% of the patients) secondary to residual prolapse or untreated clefts. In a minority of cases (<15%), the residual regurgitation was due to more technical issues including tissue laceration, ring dehiscence, residual annular dilatation, iatrogenic mitral stenosis or leaflet restriction.
SAM refractory to conservative manoeuvres accounted for one-fourth of the second cross-clamping. Intraoperative echocardiography, particularly after the introduction of 3D TOE, could correctly identify most of the mechanisms of suboptimal repair with good agreement with surgical findings. Although SAM and residual prolapse were easy to diagnose, the distinction between clefts and tissue laceration was more challenging, particularly before the introduction of 3D TOE. Indeed, in 4 patients, additional prolapsing lesions were found intraoperatively, in addition to the clefts that were shown on TOE.
The rescue procedures included all kinds of technical solutions (EE, neochordae, resection, cleft closure, change of annuloplasty ring and repair of tissue laceration). Because of its rapidity and effectiveness, the EE was used in most of the cases. However, none of the 94 patients had a clinically relevant stenosis after the second cross-clamping. The additional cross-clamp time in the second cross-clamping patients was relatively short. This was probably important for the hospital outcomes. Indeed, mortality, postoperative complications and length of hospital stay were not stastically different between the 2 groups. The overall rate of mitral replacement in this series was very low (1%) and the immediate echocardiographic results were excellent: 98% of the second cross-clamping patients were discharged with no SAM and none or mild MR. A suboptimal result (residual moderate MR) was accepted after revision of the repair in 1 patient submitted to mitral repair, tricuspid annuloplasty and maze operation for atrial fibrillation ablation. The patient had already undergone a long operation and LV dysfunction was present after the rescue procedure, thus preventing further repair attempts. When compared with the 2224 patients belonging to the control group, no differences were found in terms of residual MR. In practice, the second cross-clamping allowed the optimization of the repair without increasing mortality or morbidity. The long-term survival of the second cross-clamping patients in our series was excellent. At 12 years, the CIF of reoperation and recurrent moderate-tosevere MR (with death as competing risk) were 5.7% and 10.3%, respectively, confirming that the restored competence of the rescued MVs remained stable in most of the patients during the long term. Unfortunately, the intraoperative findings in the patients who were reoperated remained unknown because surgery was performed in other institutions. A reassuring finding is also the fact that no patient required reoperation for mitral stenosis.
Limitations
Data were retrospectively collected with all possible limitations related to this model of analysis. While hospital outcomes could be compared between the second cross-clamping and the control patients, the follow-up was available only for the second cross-clamping group. Therefore, late deaths, reoperation and recurrence of MR could not be matched with the control patients. In addition, about 35% of the patients had their echocardiographic examination at follow-up performed in other centres, and the echo reports were simply sent for our evaluation. Therefore, parameters such as LV/right ventricular dimensions and SPAP were not systematically measured and therefore they could not be used for analysis.
CONCLUSION
In conclusion, because suboptimal immediate results are associated with impaired late outcomes of MV reconstruction, a low threshold for the second cross-clamping seems to be justified. If the second repair is carried out with a relatively shorter additional cross-clamping time, mortality and morbidity are not increased and immediate and long-term results can be excellent.
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